Aufa, S. and Ismy, J. 2026. Sequential Gemcitabine and Docetaxel Versus BCG for High-Risk Non-Muscle-Invasive Bladder Cancer. Indonesian Journal of Global Health Research. 8, 6 (Sep. 2026), 89–98. DOI:https://doi.org/10.37287/ijghr.v8i6.2572.